English
简体中文
Total: £ 56.28
Published Date: 2024-04-07 | Pages: 96 | Tables: 205 | Pharma & Healthcare
Short Sleep Syndrome is a sleep condition characterized by sleeping for fewer than six hours each night . Most adults need seven or more hours of sleep each night to feel rested in the morning.
The global market for Short Sleep Syndrome Treatment was estimated to be worth US$ 8690 million in 2023 and is forecast to a readjusted size of US$ 15900 million by 2030 with a CAGR of 9.0% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Short Sleep Syndrome Treatment, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Short Sleep Syndrome Treatment by region & country, by Type, and by Application.
The Short Sleep Syndrome Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Short Sleep Syndrome Treatment.
Market Segmentation
By Company
Merck & co.
Mylan N.V.
Paratek pharmaceuticals
Pfizer Inc.
Sanofi S.A.
Sumitomo Dainippon pharma Co. Ltd.
Takeda Pharmaceuticals Company Ltd.
Teva Pharmaceutical Industries Ltd.
Vanda Pharmaceuticals Inc.
Segment by Type:
Benzodiazepines
Nonbenzodiazepines
Antidepressants
Orexin Antagonist
Melatonin Antagonist
Other
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Short Sleep Syndrome Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Short Sleep Syndrome Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Short Sleep Syndrome Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Short Sleep Syndrome Treatment Product Introduction
1.2 Global Short Sleep Syndrome Treatment Market Size Forecast
1.2.1 Global Short Sleep Syndrome Treatment Sales Value (2019-2030)
1.2.2 Global Short Sleep Syndrome Treatment Sales Volume (2019-2030)
1.2.3 Global Short Sleep Syndrome Treatment Sales Price (2019-2030)
1.3 Short Sleep Syndrome Treatment Market Trends & Drivers
1.3.1 Short Sleep Syndrome Treatment Industry Trends
1.3.2 Short Sleep Syndrome Treatment Market Drivers & Opportunity
1.3.3 Short Sleep Syndrome Treatment Market Challenges
1.3.4 Short Sleep Syndrome Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Short Sleep Syndrome Treatment Players Revenue Ranking (2023)
2.2 Global Short Sleep Syndrome Treatment Revenue by Company (2019-2024)
2.3 Global Short Sleep Syndrome Treatment Players Sales Volume Ranking (2023)
2.4 Global Short Sleep Syndrome Treatment Sales Volume by Company Players (2019-2024)
2.5 Global Short Sleep Syndrome Treatment Average Price by Company (2019-2024)
2.6 Key Manufacturers Short Sleep Syndrome Treatment Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Short Sleep Syndrome Treatment Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Short Sleep Syndrome Treatment
2.9 Short Sleep Syndrome Treatment Market Competitive Analysis
2.9.1 Short Sleep Syndrome Treatment Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Short Sleep Syndrome Treatment Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Sleep Syndrome Treatment as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Benzodiazepines
3.1.2 Nonbenzodiazepines
3.1.3 Antidepressants
3.1.4 Orexin Antagonist
3.1.5 Melatonin Antagonist
3.1.6 Other
3.2 Global Short Sleep Syndrome Treatment Sales Value by Type
3.2.1 Global Short Sleep Syndrome Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Short Sleep Syndrome Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Short Sleep Syndrome Treatment Sales Value, by Type (%) (2019-2030)
3.3 Global Short Sleep Syndrome Treatment Sales Volume by Type
3.3.1 Global Short Sleep Syndrome Treatment Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Short Sleep Syndrome Treatment Sales Volume, by Type (2019-2030)
3.3.3 Global Short Sleep Syndrome Treatment Sales Volume, by Type (%) (2019-2030)
3.4 Global Short Sleep Syndrome Treatment Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Short Sleep Syndrome Treatment Sales Value by Application
4.2.1 Global Short Sleep Syndrome Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Short Sleep Syndrome Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Short Sleep Syndrome Treatment Sales Value, by Application (%) (2019-2030)
4.3 Global Short Sleep Syndrome Treatment Sales Volume by Application
4.3.1 Global Short Sleep Syndrome Treatment Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Short Sleep Syndrome Treatment Sales Volume, by Application (2019-2030)
4.3.3 Global Short Sleep Syndrome Treatment Sales Volume, by Application (%) (2019-2030)
4.4 Global Short Sleep Syndrome Treatment Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Short Sleep Syndrome Treatment Sales Value by Region
5.1.1 Global Short Sleep Syndrome Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Short Sleep Syndrome Treatment Sales Value by Region (2019-2024)
5.1.3 Global Short Sleep Syndrome Treatment Sales Value by Region (2025-2030)
5.1.4 Global Short Sleep Syndrome Treatment Sales Value by Region (%), (2019-2030)
5.2 Global Short Sleep Syndrome Treatment Sales Volume by Region
5.2.1 Global Short Sleep Syndrome Treatment Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Short Sleep Syndrome Treatment Sales Volume by Region (2019-2024)
5.2.3 Global Short Sleep Syndrome Treatment Sales Volume by Region (2025-2030)
5.2.4 Global Short Sleep Syndrome Treatment Sales Volume by Region (%), (2019-2030)
5.3 Global Short Sleep Syndrome Treatment Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Short Sleep Syndrome Treatment Sales Value, 2019-2030
5.4.2 North America Short Sleep Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Short Sleep Syndrome Treatment Sales Value, 2019-2030
5.5.2 Europe Short Sleep Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Short Sleep Syndrome Treatment Sales Value, 2019-2030
5.6.2 Asia Pacific Short Sleep Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Short Sleep Syndrome Treatment Sales Value, 2019-2030
5.7.2 South America Short Sleep Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Short Sleep Syndrome Treatment Sales Value, 2019-2030
5.8.2 Middle East & Africa Short Sleep Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Short Sleep Syndrome Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Short Sleep Syndrome Treatment Sales Value
6.2.1 Key Countries/Regions Short Sleep Syndrome Treatment Sales Value, 2019-2030
6.2.2 Key Countries/Regions Short Sleep Syndrome Treatment Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Short Sleep Syndrome Treatment Sales Value, 2019-2030
6.3.2 United States Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Short Sleep Syndrome Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Short Sleep Syndrome Treatment Sales Value, 2019-2030
6.4.2 Europe Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Short Sleep Syndrome Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Short Sleep Syndrome Treatment Sales Value, 2019-2030
6.5.2 China Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Short Sleep Syndrome Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Short Sleep Syndrome Treatment Sales Value, 2019-2030
6.6.2 Japan Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Short Sleep Syndrome Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Short Sleep Syndrome Treatment Sales Value, 2019-2030
6.7.2 South Korea Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Short Sleep Syndrome Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Short Sleep Syndrome Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Short Sleep Syndrome Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Short Sleep Syndrome Treatment Sales Value, 2019-2030
6.9.2 India Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Short Sleep Syndrome Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merck & co.
7.1.1 Merck & co. Company Information
7.1.2 Merck & co. Introduction and Business Overview
7.1.3 Merck & co. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Merck & co. Short Sleep Syndrome Treatment Product Offerings
7.1.5 Merck & co. Recent Development
7.2 Mylan N.V.
7.2.1 Mylan N.V. Company Information
7.2.2 Mylan N.V. Introduction and Business Overview
7.2.3 Mylan N.V. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Mylan N.V. Short Sleep Syndrome Treatment Product Offerings
7.2.5 Mylan N.V. Recent Development
7.3 Paratek pharmaceuticals
7.3.1 Paratek pharmaceuticals Company Information
7.3.2 Paratek pharmaceuticals Introduction and Business Overview
7.3.3 Paratek pharmaceuticals Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Paratek pharmaceuticals Short Sleep Syndrome Treatment Product Offerings
7.3.5 Paratek pharmaceuticals Recent Development
7.4 Pfizer Inc.
7.4.1 Pfizer Inc. Company Information
7.4.2 Pfizer Inc. Introduction and Business Overview
7.4.3 Pfizer Inc. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Pfizer Inc. Short Sleep Syndrome Treatment Product Offerings
7.4.5 Pfizer Inc. Recent Development
7.5 Sanofi S.A.
7.5.1 Sanofi S.A. Company Information
7.5.2 Sanofi S.A. Introduction and Business Overview
7.5.3 Sanofi S.A. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Sanofi S.A. Short Sleep Syndrome Treatment Product Offerings
7.5.5 Sanofi S.A. Recent Development
7.6 Sumitomo Dainippon pharma Co. Ltd.
7.6.1 Sumitomo Dainippon pharma Co. Ltd. Company Information
7.6.2 Sumitomo Dainippon pharma Co. Ltd. Introduction and Business Overview
7.6.3 Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Product Offerings
7.6.5 Sumitomo Dainippon pharma Co. Ltd. Recent Development
7.7 Takeda Pharmaceuticals Company Ltd.
7.7.1 Takeda Pharmaceuticals Company Ltd. Company Information
7.7.2 Takeda Pharmaceuticals Company Ltd. Introduction and Business Overview
7.7.3 Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Product Offerings
7.7.5 Takeda Pharmaceuticals Company Ltd. Recent Development
7.8 Teva Pharmaceutical Industries Ltd.
7.8.1 Teva Pharmaceutical Industries Ltd. Company Information
7.8.2 Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
7.8.3 Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Product Offerings
7.8.5 Teva Pharmaceutical Industries Ltd. Recent Development
7.9 Vanda Pharmaceuticals Inc.
7.9.1 Vanda Pharmaceuticals Inc. Company Information
7.9.2 Vanda Pharmaceuticals Inc. Introduction and Business Overview
7.9.3 Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Product Offerings
7.9.5 Vanda Pharmaceuticals Inc. Recent Development
8 Industry Chain Analysis
8.1 Short Sleep Syndrome Treatment Industrial Chain
8.2 Short Sleep Syndrome Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Short Sleep Syndrome Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Short Sleep Syndrome Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Short Sleep Syndrome Treatment Market Trends
Table 2. Short Sleep Syndrome Treatment Market Drivers & Opportunity
Table 3. Short Sleep Syndrome Treatment Market Challenges
Table 4. Short Sleep Syndrome Treatment Market Restraints
Table 5. Global Short Sleep Syndrome Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Short Sleep Syndrome Treatment Revenue Market Share by Company (2019-2024)
Table 7. Global Short Sleep Syndrome Treatment Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Short Sleep Syndrome Treatment Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Short Sleep Syndrome Treatment Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Short Sleep Syndrome Treatment Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Short Sleep Syndrome Treatment Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Short Sleep Syndrome Treatment
Table 13. Global Short Sleep Syndrome Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Sleep Syndrome Treatment as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Short Sleep Syndrome Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Short Sleep Syndrome Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Short Sleep Syndrome Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Short Sleep Syndrome Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Short Sleep Syndrome Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Short Sleep Syndrome Treatment Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Short Sleep Syndrome Treatment Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Short Sleep Syndrome Treatment Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Short Sleep Syndrome Treatment Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Short Sleep Syndrome Treatment Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Short Sleep Syndrome Treatment Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Short Sleep Syndrome Treatment Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Short Sleep Syndrome Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Short Sleep Syndrome Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Short Sleep Syndrome Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Short Sleep Syndrome Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Short Sleep Syndrome Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Short Sleep Syndrome Treatment Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Short Sleep Syndrome Treatment Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Short Sleep Syndrome Treatment Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Short Sleep Syndrome Treatment Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Short Sleep Syndrome Treatment Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Short Sleep Syndrome Treatment Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Short Sleep Syndrome Treatment Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Short Sleep Syndrome Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Short Sleep Syndrome Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Short Sleep Syndrome Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Short Sleep Syndrome Treatment Sales Value by Region (2019-2024) & (%)
Table 44. Global Short Sleep Syndrome Treatment Sales Value by Region (2025-2030) & (%)
Table 45. Global Short Sleep Syndrome Treatment Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Short Sleep Syndrome Treatment Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Short Sleep Syndrome Treatment Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Short Sleep Syndrome Treatment Sales Volume by Region (2019-2024) & (%)
Table 49. Global Short Sleep Syndrome Treatment Sales Volume by Region (2025-2030) & (%)
Table 50. Global Short Sleep Syndrome Treatment Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Short Sleep Syndrome Treatment Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Short Sleep Syndrome Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Short Sleep Syndrome Treatment Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Short Sleep Syndrome Treatment Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Short Sleep Syndrome Treatment Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Short Sleep Syndrome Treatment Sales Volume, (2025-2030) & (K Units)
Table 57. Merck & co. Company Information
Table 58. Merck & co. Introduction and Business Overview
Table 59. Merck & co. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Merck & co. Short Sleep Syndrome Treatment Product Offerings
Table 61. Merck & co. Recent Development
Table 62. Mylan N.V. Company Information
Table 63. Mylan N.V. Introduction and Business Overview
Table 64. Mylan N.V. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Mylan N.V. Short Sleep Syndrome Treatment Product Offerings
Table 66. Mylan N.V. Recent Development
Table 67. Paratek pharmaceuticals Company Information
Table 68. Paratek pharmaceuticals Introduction and Business Overview
Table 69. Paratek pharmaceuticals Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Paratek pharmaceuticals Short Sleep Syndrome Treatment Product Offerings
Table 71. Paratek pharmaceuticals Recent Development
Table 72. Pfizer Inc. Company Information
Table 73. Pfizer Inc. Introduction and Business Overview
Table 74. Pfizer Inc. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Pfizer Inc. Short Sleep Syndrome Treatment Product Offerings
Table 76. Pfizer Inc. Recent Development
Table 77. Sanofi S.A. Company Information
Table 78. Sanofi S.A. Introduction and Business Overview
Table 79. Sanofi S.A. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Sanofi S.A. Short Sleep Syndrome Treatment Product Offerings
Table 81. Sanofi S.A. Recent Development
Table 82. Sumitomo Dainippon pharma Co. Ltd. Company Information
Table 83. Sumitomo Dainippon pharma Co. Ltd. Introduction and Business Overview
Table 84. Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Product Offerings
Table 86. Sumitomo Dainippon pharma Co. Ltd. Recent Development
Table 87. Takeda Pharmaceuticals Company Ltd. Company Information
Table 88. Takeda Pharmaceuticals Company Ltd. Introduction and Business Overview
Table 89. Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Product Offerings
Table 91. Takeda Pharmaceuticals Company Ltd. Recent Development
Table 92. Teva Pharmaceutical Industries Ltd. Company Information
Table 93. Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
Table 94. Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Product Offerings
Table 96. Teva Pharmaceutical Industries Ltd. Recent Development
Table 97. Vanda Pharmaceuticals Inc. Company Information
Table 98. Vanda Pharmaceuticals Inc. Introduction and Business Overview
Table 99. Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Product Offerings
Table 101. Vanda Pharmaceuticals Inc. Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Short Sleep Syndrome Treatment Downstream Customers
Table 105. Short Sleep Syndrome Treatment Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Short Sleep Syndrome Treatment Product Picture
Figure 2. Global Short Sleep Syndrome Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Short Sleep Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Short Sleep Syndrome Treatment Sales Volume (2019-2030) & (K Units)
Figure 5. Global Short Sleep Syndrome Treatment Sales Price (2019-2030) & (US$/Unit)
Figure 6. Short Sleep Syndrome Treatment Report Years Considered
Figure 7. Global Short Sleep Syndrome Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Short Sleep Syndrome Treatment Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Short Sleep Syndrome Treatment Revenue in 2023
Figure 10. Short Sleep Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Benzodiazepines Picture
Figure 12. Nonbenzodiazepines Picture
Figure 13. Antidepressants Picture
Figure 14. Orexin Antagonist Picture
Figure 15. Melatonin Antagonist Picture
Figure 16. Other Picture
Figure 17. Global Short Sleep Syndrome Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Short Sleep Syndrome Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 19. Global Short Sleep Syndrome Treatment Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 20. Global Short Sleep Syndrome Treatment Sales Volume Market Share by Type, 2023 & 2030
Figure 21. Global Short Sleep Syndrome Treatment Price by Type (2019-2030) & (US$/Unit)
Figure 22. Product Picture of Hospital Pharmacies
Figure 23. Product Picture of Retail Pharmacies
Figure 24. Product Picture of Online Pharmacies
Figure 25. Global Short Sleep Syndrome Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 26. Global Short Sleep Syndrome Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 27. Global Short Sleep Syndrome Treatment Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 28. Global Short Sleep Syndrome Treatment Sales Volume Market Share by Application, 2023 & 2030
Figure 29. Global Short Sleep Syndrome Treatment Price by Application (2019-2030) & (US$/Unit)
Figure 30. North America Short Sleep Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
Figure 31. North America Short Sleep Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
Figure 32. Europe Short Sleep Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
Figure 33. Europe Short Sleep Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
Figure 34. Asia Pacific Short Sleep Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Short Sleep Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
Figure 36. South America Short Sleep Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
Figure 37. South America Short Sleep Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
Figure 38. Middle East & Africa Short Sleep Syndrome Treatment Sales Value (2019-2030) & (US$ Million)
Figure 39. Middle East & Africa Short Sleep Syndrome Treatment Sales Value by Country (%), 2023 VS 2030
Figure 40. Key Countries/Regions Short Sleep Syndrome Treatment Sales Value (%), (2019-2030)
Figure 41. Key Countries/Regions Short Sleep Syndrome Treatment Sales Volume (%), (2019-2030)
Figure 42. United States Short Sleep Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 43. United States Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
Figure 44. United States Short Sleep Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
Figure 45. Europe Short Sleep Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 46. Europe Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
Figure 47. Europe Short Sleep Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
Figure 48. China Short Sleep Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 49. China Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
Figure 50. China Short Sleep Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
Figure 51. Japan Short Sleep Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 52. Japan Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
Figure 53. Japan Short Sleep Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
Figure 54. South Korea Short Sleep Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 55. South Korea Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
Figure 56. South Korea Short Sleep Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
Figure 57. Southeast Asia Short Sleep Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 58. Southeast Asia Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
Figure 59. Southeast Asia Short Sleep Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
Figure 60. India Short Sleep Syndrome Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 61. India Short Sleep Syndrome Treatment Sales Value by Type (%), 2023 VS 2030
Figure 62. India Short Sleep Syndrome Treatment Sales Value by Application (%), 2023 VS 2030
Figure 63. Short Sleep Syndrome Treatment Industrial Chain
Figure 64. Short Sleep Syndrome Treatment Manufacturing Cost Structure
Figure 65. Channels of Distribution (Direct Sales, and Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
